missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Taurodeoxycholic acid sodium hydrate, MedChemExpress
Description
Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate) prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation. Taurodeoxycholic acid sodium hydrate is investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis.
Specifications
Specifications
| Chemical Name or Material | Taurodeoxycholic acid sodium hydrate |
| CAS | 110026-03-4 |
| Color | White |
| Purity Grade Notes | Research |
| Molecular Formula | C26H46NNaO7S |
| Quantity | 50 mg |
| Synonym | Sodium taurodeoxycholate monohydrate |
| Solubility Information | DMSO : 125 mg/mL (231.61 mM; Need ultrasonic) |
| SMILES | C[C@H](CCC(NCCS(=O)(O[Na])=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C.O |
| Molecular Weight (g/mol) | 539.7 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?